Espironolactona

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Espironolactona

Property Description
Active ingredient Spironolactone
Form Tablet, Oral suspension
Pharmacological class Potassium-sparing diuretic, Aldosterone antagonist
Common use Fluid balance regulation
Origin Synthetic, Steroidal compound

Espironolactona, known by its active ingredient Spironolactone (INN), is a distinct synthetic compound derived from a steroidal structure. It is primarily classified within the pharmacological class of potassium-sparing diuretics, which are agents designed to facilitate the excretion of excess fluid. Crucially, Spironolactone is also a Mineralocorticoid Receptor Antagonist (MRA), a classification that underscores its targeted action against the hormone aldosterone. This dual classification is clinically recognized for providing effective fluid management while simultaneously protecting essential electrolyte levels.

Spironolactone is intended for oral administration, available as both a tablet and, in certain markets, an oral suspension. The medication functions as a prodrug, meaning the administered compound is chemically converted into highly active metabolites, such as Canrenone, before exerting its full effect. This composition allows it to block the specific kidney receptors that aldosterone normally signals to retain sodium and water. This mechanism works by decreasing the amount of water and sodium reabsorbed in the kidneys, which explains how the medicine effectively reduces overall fluid retention.

Its unique pharmacological profile—blocking aldosterone and conserving potassium—is a key differentiating factor from many non-antagonist diuretics, making it the agent of choice in scenarios requiring precise electrolyte management. Its well-documented secondary effect as an antiandrogen is another distinguishing characteristic, offering therapeutic utility beyond simple fluid regulation. Popular brand-name formulations containing Spironolactone include Aldactone and CaroSpir, both of which maintain this specific therapeutic profile.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. MedlinePlus, NIH

What side effects are possible with Espironolactona?

Official Safety Profile and Adverse Reactions

The safety profile of Espironolactona is extensively documented in official regulatory sources, with potential adverse reactions classified by frequency and affected physiological system. The most frequently cited adverse reaction across all regulatory documents is hyperkalemia (elevated serum potassium levels), which is classified as very common in official labeling, reflecting the drug’s primary mechanism as a potassium-sparing agent.

Adverse effects considered common include headache, various gastrointestinal disturbances, and effects related to the drug's anti-androgen activity. These commonly reported effects include gynecomastia (enlargement of male breast tissue) and menstrual cycle irregularities in women. Gynecomastia is generally associated with the duration of use and dose level.

Reactions classified as uncommon include central nervous system effects such as lethargy and mental confusion, and various skin reactions like rash and urticaria. Rare but serious safety concerns documented in regulatory text include severe conditions such as Agranulocytosis, Hepatitis, Acute Kidney Injury, and severe cutaneous adverse reactions like Stevens-Johnson syndrome (SJS).

Safety Constraints and Special Populations

The medication is subject to several safety restrictions explicitly listed in official labeling. Espironolactona is contraindicated in patients with pre-existing hyperkalemia, Addison's disease, anuria, or significant impairment of renal or hepatic function. Specifically, older adults and patients with reduced kidney function are identified as populations with an increased risk for developing severe hyperkalemia.

Overdose and Emergency Response

Overdose and When to Seek Help

Acute overdose of Espironolactona (Spironolactone) is primarily associated with symptoms that include drowsiness, mental confusion, dizziness, nausea, vomiting, or diarrhea. The immediate medical concern following an overdose involves severe disturbances in the body's fluid and electrolyte balance, which can lead to life-threatening complications.

Overdose Risks and Management

  • Critical Physiological Risks: The most critical risk is hyperkalemia (excessive potassium in the blood), especially in patients with pre-existing impaired renal function. Rarely, hyponatremia (low sodium) or hepatic coma may occur in individuals with severe liver disease.
  • Required Emergency Action: There is no specific antidote for an overdose of this medication. Treatment is supportive, focusing on correcting the potentially life-threatening electrolyte imbalance, maintaining hydration, and supporting vital functions. The first step in management is the discontinuation of the drug and restriction of potassium intake.

When to Seek Immediate Medical Help

Immediate medical attention is required if an overdose is suspected, even if symptoms are not yet apparent. Emergency services should be called if the individual has collapsed, experienced a seizure, has trouble breathing, or is unable to be awakened. You must contact a Poison Control Center immediately for professional guidance.

Therapeutic Uses of Espironolactona

The primary therapeutic benefit of Espironolactona is commonly used to offer targeted support in clinical situations marked by complex fluid imbalances and certain hormonal excesses, contributing to easing the overall symptom load. The medication may be part of symptomatic management for a variety of conditions related to volume and pressure management.


Therapeutic Focus and Symptom Relief

Espironolactona is applied across domains where additional symptomatic support is needed, primarily for conditions presenting with systemic or localized discomfort. It is used for managing pronounced symptoms related to systemic imbalance like fluid overload and swelling (edema and ascites), and is used for managing symptoms related to heightened physiological activity like high blood pressure in resistant hypertension. In specific patient groups, it can also manage symptoms related to heightened physiological activity linked to androgen excess, such as persistent acne or unwelcome hirsutism.

“This therapeutic domain provides support that helps ease the overall symptom burden.”

Quick Fact: Relief for Fluid Overload The medication provides supportive relief for this excess volume, which contributes to improved comfort and reduced symptoms that interfere with daily functioning.


This application is applied in clinical settings that involve acute or unstable symptom patterns and contributes to improved day-to-day comfort during symptomatic periods, particularly in conditions characterized by periods of heightened symptoms.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Population Eligibility for Espironolactona

Eligibility for Espironolactona (Spironolactone) is strictly defined by government regulatory agencies based on the potential for serious adverse outcomes related to its potassium-sparing action. The primary rules for who is eligible and who is prohibited come directly from regulatory labeling.

Absolute Contraindications (Must Not Use)

The medicine is strictly contraindicated and must not be used in populations presenting with the following conditions:

  • Hyperkalemia: Significantly elevated serum potassium levels.
  • Anuria: Inability to produce urine, or significant renal excretory impairment.
  • Addison's Disease: Primary adrenal insufficiency.
  • Severe Renal Impairment: Including acute kidney failure or severe chronic kidney disease (e.g., GFR leq 30 mL/min).

Restricted or Conditional Use

Use is established in adults but requires caution or specialist guidance in other groups:

  • Geriatric Patients: Caution is required, and lower initial doses may be recommended due to the greater prevalence of reduced renal function and associated hyperkalemia risk.
  • Pediatric Patients: Use should only occur under the direction of a paediatric specialist, reflecting limited long-term safety data in this age group.
  • Hepatic Impairment: Patients with impaired liver function should be monitored closely, as use may precipitate hepatic coma.

Pregnancy and Lactation Eligibility Status

  • Pregnancy: Use is generally not recommended unless the potential therapeutic benefit is determined to outweigh the potential risk to the fetus.
  • Lactation: Regulatory guidance advises that a decision must be made to either discontinue breastfeeding or discontinue the drug, taking into account the drug's importance to the mother.

What should I know about interactions with other medicines?

Official Interaction Profile

The interactions of Espironolactona (Spironolactone) are formally documented by regulatory authorities, largely focusing on the potential for pharmacodynamic effects that disrupt electrolyte balance and pharmacokinetic effects that modify drug exposure.

Interaction Classification Interacting Agents / Classes Regulatory Outcome
Contraindicated Combinations Eplerenone, other Potassium-Sparing Diuretics (e.g., Triamterene) Prohibited co-administration due to severe, additive risk of hyperkalemia.
High Hyperkalemia Risk ACE Inhibitors, ARBs, Potassium Supplements, Heparins, Trimethoprim Increased risk of severe hyperkalemia when co-administered.
Efficacy/Exposure Impact NSAIDs (e.g., Indomethacin), Digoxin, Lithium NSAIDs may reduce diuretic efficacy. Spironolactone increases exposure to Digoxin and Lithium by reducing their clearance.

Food and Administration Constraints Co-administration with food increases the absorption and bioavailability of Espironolactona. Regulatory guidance mandates a consistent administration routine—always taking the medicine with food or always without—to ensure predictable and stable drug levels. The risk of interaction-related hyperkalemia is officially noted to be increased in patients with renal impairment and in elderly patients when potassium-retaining agents are concurrently used. Co-administration with Abiraterone is formally not recommended.

Mechanism of Action

Competitive Blockade of the Mineralocorticoid Receptor

This primary mechanism involves Spironolactone binding to and competitively blocking the aldosterone receptor in the epithelial cells of the kidney's collecting ducts. This engagement of the receptor-mediated signaling cascade leads to the inhibition of sodium reabsorption and potassium secretion across the cell membrane, which alters ion transport, causing decreased sodium reabsorption and increased potassium retention.


Modulating Androgen and Progesterone Receptor Activity

Beyond its main renal action, the drug and its metabolites engage mechanisms that regulate other steroid hormone receptors, acting as an antagonist at the androgen receptor (AR) and an agonist at the progesterone receptor (PR). This interaction alters the transcription factor activity typically driven by androgens in target cells, which consequently influences downstream gene expression patterns regulated by these receptors.

Dosage and Administration Information

Spironolactone (Espironolactona) is available as an oral tablet and is typically taken once daily. It is critical to take this medication exactly as prescribed by your healthcare provider, following all directions on your prescription label. Your doctor will determine the appropriate dose based on your specific medical condition, which may include heart failure, hypertension (high blood pressure), or edema (fluid retention) associated with conditions like hepatic cirrhosis or nephrotic syndrome.

Administration Guidelines

Guideline Instruction
Dosing Schedule Usually taken once daily, often in the morning, to minimize night-time urination.
With Food Take with a meal or consistently without food. Taking it with food may help the body absorb the medicine more effectively.
Missed Dose If you miss a dose, take it as soon as you remember, unless it is close to the time for your next scheduled dose (e.g., after 6 PM). In that case, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed one.
Duration Spironolactone may be a long-term treatment. Do not stop taking it without consulting your doctor, even if you feel well, as stopping prematurely can worsen your condition.

Important Monitoring

Since spironolactone is a potassium-sparing diuretic, your doctor will monitor your blood pressure, kidney function, and serum potassium levels frequently throughout treatment. This is vital because high potassium levels (hyperkalemia) can be a serious side effect.

Recent Clinical Evidence

Espironolactona: Recent Clinical Evidence

Mechanism and Primary Applications

Spironolactone is an aldosterone receptor antagonist that is also classified as a potassium-sparing diuretic. In cardiovascular and fluid-retention applications, it functions by blocking the effects of the hormone aldosterone, which promotes the excretion of excess sodium and water while promoting the retention of potassium. This action is central to its role in managing conditions related to fluid overload and hypertension.

Key research has centered on its use in three primary clinical areas:


Heart Failure and Cardiovascular Outcomes

Clinical trials have established the value of spironolactone in the management of Heart Failure with Reduced Ejection Fraction (HFrEF). Landmark studies reported that when added to standard therapy, spironolactone was associated with a reduction in the risk of both mortality and hospitalization for cardiac causes. More recent studies have explored its potential benefits following a heart attack, where it was reported to reduce the risk of developing new or worsening heart failure, although it did not show a significant impact on overall mortality.


️ Edema and Resistant Hypertension

Spironolactone is widely studied for treating fluid retention (edema and ascites) associated with liver cirrhosis and nephrotic syndrome. Research generally indicates that it is effective in mobilizing ascites, often used in combination with loop diuretics (such as furosemide). For resistant hypertension—blood pressure that remains high despite the use of multiple other medications—clinical evidence supports the addition of spironolactone to multidrug regimens to help achieve blood pressure control.


Hormonal/Off-label Use

Research has explored the anti-androgenic properties of spironolactone, which involve blocking androgen receptors. This property is the basis for its widespread study and use in managing acne vulgaris and hirsutism in women, often at doses higher than those used for cardiovascular conditions. Studies tracking the use of spironolactone for acne have reported that it is generally well-tolerated in young, healthy women over long periods, with common reported side effects being menstrual irregularities and breast tenderness.

Key Studies & References Cardiovascular Benefits of Spironolactone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from a Win Ratio Analysis of the TOPCAT Trial

Frequently Asked Questions (FAQ)

Common questions about Espironolactona (FAQ)


Q: Are there generic versions of Spironolactone, and are they the same?

Yes, Spironolactone is widely available in generic versions, often alongside the brand name formulations like Aldactone. According to official regulatory agencies, generic products must be bioequivalent to the brand-name drug. This means they are required to have the same active ingredient, strength, quality, stability, and therapeutic effectiveness.

Q: Can Spironolactone cause kidney problems?

Regulatory documents indicate that renal dysfunction (kidney problems), including renal failure, is a reported adverse reaction. The drug is substantially processed by the kidneys, and official information notes that people who already have impaired renal function (reduced kidney function) are at a greater risk for adverse reactions while using this medication.

Q: Can Spironolactone affect mood or cause anxiety?

Official labeling lists some effects on the central nervous system, such as lethargy, mental confusion, dizziness, and drowsiness. However, official regulatory sources generally list a defined set of adverse reactions by frequency, and specific emotional or mood disorders, such as anxiety, are not commonly listed in labeling.

Q: Can a low-sodium diet improve the effectiveness of Spironolactone?

The mechanism of Spironolactone involves increasing the excretion of sodium and water. Official information indicates the drug is used for fluid retention conditions that are not resolved by fluid and sodium restriction alone. A reduced-salt diet is a general lifestyle measure that supports the management of blood pressure and fluid retention, which aligns with the drug's therapeutic goals.

Q: Does Spironolactone affect liver function?

Official information notes rare reports of mixed cholestatic/hepatocellular toxicity (damage to liver cells). Caution is advised when Spironolactone is used in patients with hepatic disease (liver disease) with cirrhosis, as regulatory warnings note a risk of potentially precipitating hepatic encephalopathy (a nervous system disorder caused by severe liver disease).

Q: Is it recommended to avoid alcohol completely while on Spironolactone?

Co-administration of Spironolactone and alcohol (ethanol) may have an additive effect in lowering blood pressure. Regulatory warnings indicate that patients may experience increased dizziness, lightheadedness, or fainting when consuming alcohol, especially during the initial phase of treatment or following a dose adjustment.

Q: Does Spironolactone have any known interactions with herbal supplements?

Official regulatory warnings focus strongly on avoiding co-administration with products, including supplements, that can significantly increase potassium levels due to the risk of hyperkalemia. It is generally important for individuals to disclose all medicines, supplements, or herbal remedies to a healthcare professional, as only known pharmaceutical interactions are typically detailed in official labeling.

Q: Why do dermatologists prescribe Spironolactone for acne?

Studies and official information indicate that Spironolactone has anti-androgenic properties, meaning it can block androgen receptors in the body. This mechanism is the basis for its widespread use in managing conditions like acne vulgaris (acne) and hirsutism in women, often prescribed by specialists such as dermatologists.

Q: Does Spironolactone help with hair loss or hirsutism?

Official clinical evidence supports the use of Spironolactone for hirsutism (excessive hair growth) in women due to its anti-androgen action. Clinical evidence has explored the use of the anti-androgenic effects of Spironolactone for managing hair thinning or androgenetic alopecia.

Q: How long does it usually take for Spironolactone to start working for acne?

Official documents often note that Spironolactone is generally used as a long-term treatment, and anti-androgen effects may take time to become noticeable. The full therapeutic benefits for acne or hirsutism are generally assessed over a period of several weeks to months of consistent administration.

Q: What happens if I forget to take my Spironolactone dose?

Administration guidelines typically state that if a dose is missed, it should be taken as soon as it is remembered. However, if the time is close to the next scheduled dose, the missed dose is usually skipped, and the regular schedule is resumed. Official guidance stresses that individuals should not double the dose to compensate for a missed dose.

Q: Can I take Spironolactone in the morning or is it better at night?

The drug is usually taken once daily. Official guidelines state that it is often taken in the morning to help minimize the need to urinate at night (nocturia). Consistency in administration is an important factor, whether the medication is taken in the morning or at a different time of day, as recommended by the prescriber.

Q: Why does Spironolactone sometimes cause menstrual irregularities in women?

Official safety data lists menstrual cycle irregularities as a common side effect for women. This is attributed to the drug's activity beyond the kidneys, where it can interact with progesterone and androgen receptors, potentially altering the natural hormonal balance that regulates the menstrual cycle.

Q: Can I drink coffee or tea while taking Spironolactone?

Official regulatory sources do not prohibit the consumption of coffee or tea. However, since Spironolactone is a diuretic and caffeine is also a diuretic, individuals may wish to be mindful of their hydration status. Any concerns about changes in urination frequency should be discussed with a healthcare provider.

Q: Can men take Spironolactone, and what are the effects?

Spironolactone is prescribed to men, primarily for conditions like heart failure and hypertension. The most common androgen-related side effect reported in men is gynecomastia (enlargement of male breast tissue), which is generally associated with the duration of use and dose level.

Q: What is the experience of people using Spironolactone for PCOS symptoms?

The anti-androgen properties of Spironolactone—blocking androgen receptors—are the same ones that treat symptoms common in Polycystic Ovary Syndrome (PCOS), such as hirsutism and acne. While PCOS is not an official indication, its use for these specific symptoms is common and supported by clinical evidence.

Q: Is it normal to urinate more frequently when first starting Spironolactone?

As Spironolactone is a diuretic, its function is to increase the excretion of fluid through the kidneys. Because of this, urinating more frequently is an expected effect when beginning the medication. Taking it earlier in the day is often recommended to manage this effect.

Q: Why might a doctor prescribe Spironolactone over a traditional diuretic for fluid retention?

Spironolactone is unique because it is a potassium-sparing diuretic and also an aldosterone antagonist. Unlike traditional diuretics, it helps the body retain potassium while still removing excess fluid and sodium. This dual mechanism is often a reason for its selection in conditions like heart failure or certain types of edema where potassium levels need careful conservation.

Q: Is there a link between Spironolactone and breast tenderness or enlargement?

Official safety data lists gynecomastia (male breast tissue enlargement) as a common side effect for men. While official labels do not explicitly list general breast tenderness or enlargement as common for women, its hormonal mechanism is noted in the drug’s profile. If any concerns regarding breast tenderness or enlargement are experienced, a healthcare provider should be consulted.

Q: Will taking Spironolactone make me more sensitive to cold temperatures?

Official regulatory sources do not list increased sensitivity to cold temperatures as a documented common or uncommon adverse reaction. The recorded central nervous system effects are primarily lethargy, dizziness, and mental confusion.

How should Espironolactona be stored and disposed of?

How to Store and Dispose of Spironolactone (Espironolactona)

Official regulatory guidelines define specific conditions for storing and disposing of Spironolactone to ensure product stability and safety.

Storage Requirements

Condition Requirement
Temperature Store tablets at Controlled Room Temperature, typically 20 C to 25 C (or below 30 C).
Protection Keep the medicine protected from light, stored in a dry place, and kept from freezing.
Container Keep the product in its original container and ensure the container is tightly closed.
Child Safety Must be kept out of the sight and reach of children.
Stability Do not use the medicine after the expiry date. Compounded liquid suspensions often have a limited stability period, such as one month when refrigerated.

Disposal Instructions

Unused or expired Spironolactone must not be thrown away via wastewater or household waste. Disposal should be managed through an authorized drug take-back program or by consulting a pharmacist for guidance on local requirements. Care is required to avoid environmental release of the product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Espironolactona found in:

A-Z Index: